Gossamer Bio, Inc.
USD0.16
+0.01 (+4.46%)
CEO
Faheem Hasnain
IPO Date
2019-02-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.16
Prev. Close
$0.16
Day Low
$0.15
Day High
$0.17
52W Low
$0.14
52W High
$3.87
Market Cap
$0.04B
Volume
14.49M
| 115,000 |
| $0.18 |
| 5 Jun 2026 | Daniel Thomas O | director | A-Award | Acquired | 115,000 | $0.18 |
| 5 Jun 2026 | Cox Russell J. | director | A-Award | Acquired | 115,000 | $0.18 |
| 5 Jun 2026 | Milligan Sandra | director | A-Award | Acquired | 115,000 | $0.18 |
| 5 Jun 2026 | Nathan Steven D | director | A-Award | Acquired | 115,000 | $0.18 |
| 20 Mar 2026 | Aranda Richard | Chief Medical Officer | D-Return | Disposed | 562,500 | $2.88 |
| 20 Mar 2026 | Aranda Richard | Chief Medical Officer | D-Return | Disposed | 572,000 | $1.13 |
| 20 Mar 2026 | Aranda Richard | Chief Medical Officer | D-Return | Disposed | 487,500 | $0.97 |
| 20 Mar 2026 | Aranda Richard | Chief Medical Officer | D-Return | Disposed | 162,500 | $0.84 |